|
(P1902) |
Dipeptidyl-peptidase 3: potential biomarker for detection of COVID-19 and association with pulmonary infiltrates |
| |
|
S. Staudner (Regensburg) |
|
(P1903) |
Morbiditäts-Beeinflussung durch Cytosorb-Filter: Eine Propensity-Score-Analyse an 631 Patienten |
| |
|
N. Bieler, S. Rohrbach, J. Schülke, A. Böning, B. Niemann (Gießen) |
|
(P1905) |
Extracorporal life support as bridging therapy in Germany |
| |
|
P. Albrecht, K. Kaier, C. Möser, A. Heidenreich, V. Oettinger, M. Zehender, C. von zur Mühlen, D. Dürschmied, C. Bode, P. Stachon (Freiburg im Breisgau, Mannheim) |
|
(P1906) |
Bioelectrical impedance analysis as a potential risk marker in adults with Marfan syndrome |
| |
|
S. Freilinger, M. Suleiman, G. Bischoff, P. Ewert, H. Kaemmerer, C. Meierhofer, N. Nagdyman, F. von Scheidt, M. Weyand, F. Harig (München, Erlangen) |
|
(P1907) |
The characteristic time course of complications occurring after interventional treatment of chronic type B aortic dissection (cTBAD) |
| |
|
D. Mohajeri, C. Rammos, K. Tsagakis, T. Schlosser, A. Ruhparwar, T. Rassaf, R. A. Janosi, J. Lortz (Essen) |